153 related articles for article (PubMed ID: 359394)
21. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
Starostina EG; Lobanova AM; Magomedova AK
Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
[TBL] [Abstract][Full Text] [Related]
22. [beta-Cell residual function in juvenile diabetes mellitus (author's transl)].
Schober E; Schernthaner G; Frisch H
Monatsschr Kinderheilkd; 1980 Dec; 128(12):776-9. PubMed ID: 6109242
[TBL] [Abstract][Full Text] [Related]
23. B-cell responses to intravenous glucose and glucagon in non-diabetic twins of patients with type 1 (insulin-dependent) diabetes mellitus.
Heaton DA; Lazarus NR; Pyke DA; Leslie RD
Diabetologia; 1989 Nov; 32(11):814-7. PubMed ID: 2687066
[TBL] [Abstract][Full Text] [Related]
24. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
25. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
Bonora E; Coscelli C; Butturini U
Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
[TBL] [Abstract][Full Text] [Related]
26. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
Faber OK
Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
[No Abstract] [Full Text] [Related]
27. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea.
Gutniak M; Karlander SG; Efendić S
Diabetes Care; 1987; 10(5):545-54. PubMed ID: 2890501
[TBL] [Abstract][Full Text] [Related]
28. Abnormal proinsulin/C-peptide ratio in juvenile diabetes.
Ludvigsson J; Heding L
Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459
[TBL] [Abstract][Full Text] [Related]
29. [Effect of hyperbaric oxygenation on residual insulin secretion in patients with diabetes mellitus type 1].
Dedov II; Lukich VL; Bol'shakova TD; Gitel' EP; Dreval' AV
Probl Endokrinol (Mosk); 1987; 33(4):10-5. PubMed ID: 3309933
[TBL] [Abstract][Full Text] [Related]
30. C-peptide in children with juvenile diabetes. A preliminary report.
Ludvigsson J; Heding LG
Diabetologia; 1976 Dec; 12(6):627-30. PubMed ID: 1001852
[TBL] [Abstract][Full Text] [Related]
31. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
Menzel R; Pusch H; Ratzmann GW; Besch W; Förster F; Albrecht G; Ruhnke R
Exp Clin Endocrinol; 1985 Feb; 85(1):81-8. PubMed ID: 3886415
[TBL] [Abstract][Full Text] [Related]
32. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus.
Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK
Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512
[TBL] [Abstract][Full Text] [Related]
33. 5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control.
Rjasanowski I; Michaelis D; Keilacker H; Besch W; Richter KV; Heinke P
Exp Clin Endocrinol; 1987 Apr; 89(2):216-24. PubMed ID: 3301371
[TBL] [Abstract][Full Text] [Related]
34. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
Faber OK; Binder C
Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
[TBL] [Abstract][Full Text] [Related]
35. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes.
Davis AK; DuBose SN; Haller MJ; Miller KM; DiMeglio LA; Bethin KE; Goland RS; Greenberg EM; Liljenquist DR; Ahmann AJ; Marcovina SM; Peters AL; Beck RW; Greenbaum CJ;
Diabetes Care; 2015 Mar; 38(3):476-81. PubMed ID: 25519448
[TBL] [Abstract][Full Text] [Related]
37. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
[TBL] [Abstract][Full Text] [Related]
38. Insulin secretion in non-obese (J-type) diabetics in Papua New Guinea.
Martin FI; Simeanova L
Aust N Z J Med; 1979 Jun; 9(3):260-2. PubMed ID: 111657
[TBL] [Abstract][Full Text] [Related]
39. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
[TBL] [Abstract][Full Text] [Related]
40. Interrelationships between body weight, insulin secretion from B cell and metabolic control in type 2 (non-insulin-dependent) diabetics with fasting hyperglycemia.
Pasquali R; Buratti P; Biso P; Mattioli L; Capelli M; Melchionda N; Labò G
Panminerva Med; 1987; 29(3):181-8. PubMed ID: 3320883
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
